• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与人类外源性物质葡萄糖醛酸化和硫酸化变异相关的遗传和环境因素。

Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.

作者信息

Burchell B, Coughtrie M W

机构信息

Department of Biochemical Medicine, Ninewells Medical School, University, Dundee, Scotland, UK.

出版信息

Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):739-47. doi: 10.1289/ehp.97105s4739.

DOI:10.1289/ehp.97105s4739
PMID:9255555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1470020/
Abstract

Glucuronidation and sulfation are phase 2 metabolic reactions catalyzed by large families of different isoenzymes in man. The textbook view that glucuronidation and sulfation lead to the production of harmless conjugates for simple excretion is not valid. Biologically active and toxic sulfates and glucuronides are produced and leed to adverse drug reactions, including immune hypersensitivity. Considerable variation in xenobiotic conjugation is observed as a result of altered expression of UDP-glucuronosyltransferases (UGTs) and sulfotransferases (STs). Recent cloning and expression of human cDNA encoding UGTs and STs has facilitated characterization of isoform substrate specificity, which has been further validated using specific antibodies and human tissue fractions. The availability of cloned/expressed human enzymes and specific antibodies has enabled the investigation of xenobiotic induction and metabolic disruption leeding to adverse responses. Genetic polymorphisms of glucuronidation and sulfation are known to exist although the characterization and assessment of the importance of these variations are hampered by appropriate ethical studies in men with suitable safe model compounds. Genetic analysis has allowed molecular identification of defects in well-known hyperbilirubinemias. However, full characterization of the specific functional roles of human UGTs and STs requires rigorous kinetic and molecular analyses of the role of each enzyme in vivo through the use of specific antibodies and inhibitors. This will leed to the better prediction of variation of xenobiotic glucuronidation and sulfation in man.

摘要

葡萄糖醛酸化和硫酸化是人体中由大量不同同工酶家族催化的Ⅱ相代谢反应。认为葡萄糖醛酸化和硫酸化会产生无害结合物以便简单排泄的传统观点并不正确。生物活性和有毒的硫酸盐及葡萄糖醛酸化物会产生,并导致药物不良反应,包括免疫超敏反应。由于尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)和磺基转移酶(STs)表达的改变,观察到外源性物质结合存在相当大的差异。最近对编码UGTs和STs的人类cDNA的克隆和表达有助于表征同工型底物特异性,使用特异性抗体和人体组织部分已进一步验证了这一点。克隆/表达的人类酶和特异性抗体的可获得性使得对外源性物质诱导和导致不良反应的代谢紊乱的研究成为可能。已知存在葡萄糖醛酸化和硫酸化的基因多态性,尽管对这些变异重要性的表征和评估因使用合适的安全模型化合物对人体进行适当的伦理研究而受到阻碍。基因分析已使人们能够从分子水平鉴定出已知的高胆红素血症中的缺陷。然而,要全面表征人类UGTs和STs的特定功能作用,需要通过使用特异性抗体和抑制剂对每种酶在体内的作用进行严格的动力学和分子分析。这将有助于更好地预测人体中外源性物质葡萄糖醛酸化和硫酸化的变异情况。

相似文献

1
Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.与人类外源性物质葡萄糖醛酸化和硫酸化变异相关的遗传和环境因素。
Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):739-47. doi: 10.1289/ehp.97105s4739.
2
Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation.人尿苷二磷酸葡萄糖醛酸基转移酶的特异性与外源性物质的葡萄糖醛酸化作用
Life Sci. 1995;57(20):1819-31. doi: 10.1016/0024-3205(95)02073-r.
3
Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation.人类尿苷二磷酸葡萄糖醛酸转移酶的遗传变异:对疾病和药物葡萄糖醛酸化的影响。
Am J Pharmacogenomics. 2003;3(1):37-52. doi: 10.2165/00129785-200303010-00006.
4
Simultaneous determination of sulfation and glucuronidation of flavones in FVB mouse intestine in vitro and in vivo.同时测定 FVB 小鼠肠内黄酮类化合物的硫酸化和葡萄糖醛酸化的体内外研究。
J Appl Toxicol. 2013 Apr;33(4):273-80. doi: 10.1002/jat.1737. Epub 2011 Dec 15.
5
Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.人源UDP-葡萄糖醛酸基转移酶1A3催化的胺类及其他外源性物质的葡萄糖醛酸化反应
Drug Metab Dispos. 1998 Jun;26(6):507-12.
6
The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.预测人体药物葡萄糖醛酸化参数:用于反应表型分析的 UDP-葡萄糖醛酸基转移酶酶选择性底物和抑制剂探针,以及用于预测药物清除率和药物相互作用潜力的体外-体内外推。
Drug Metab Rev. 2010 Feb;42(1):196-208. doi: 10.3109/03602530903210716.
7
Drug and xenobiotic glucuronidation catalysed by cloned human liver UDP-Glucuronosyltransferases stably expressed in tissue culture cell lines.在组织培养细胞系中稳定表达的克隆人肝脏尿苷二磷酸葡萄糖醛酸基转移酶催化的药物和外源性物质葡萄糖醛酸化。
Toxicology. 1993 Oct 5;82(1-3):119-29. doi: 10.1016/0300-483x(93)02607-i.
8
Use of cloned and expressed human liver UDP-glucuronosyltransferases for analysis of drug glucuronide formation and assessment of drug toxicity.利用克隆和表达的人肝脏UDP-葡萄糖醛酸转移酶分析药物葡萄糖醛酸苷的形成及评估药物毒性。
Environ Health Perspect. 1994 Nov;102 Suppl 9(Suppl 9):19-23. doi: 10.1289/ehp.94102s919.
9
Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.酚类的区域选择性硫酸化和葡萄糖醛酸化:结构基础的深入了解。
Curr Drug Metab. 2011 Nov;12(9):900-16. doi: 10.2174/138920011797470100.
10
Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions.葡萄糖醛酸化及UDP-葡萄糖醛酸基转移酶在异生物质生物活化反应中的作用。
Chem Biol Interact. 2000 Dec 1;129(1-2):171-93. doi: 10.1016/s0009-2797(00)00198-8.

引用本文的文献

1
Uremic Toxins and Vascular Dysfunction.尿毒症毒素与血管功能障碍
Toxins (Basel). 2020 Jun 18;12(6):404. doi: 10.3390/toxins12060404.
2
Low Plasma Appearance of (+)-Catechin and (-)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa-A Randomized, Double-Blind Trial.饮用未碱化或碱化可可制备的饮料后,(+)-儿茶素和(-)-儿茶素与表儿茶素的血浆浓度相比降低:一项随机、双盲试验。
Nutrients. 2020 Jan 16;12(1):231. doi: 10.3390/nu12010231.
3
Synthetic Pot: Not Your Grandfather's Marijuana.合成大麻:并非你祖父时代的大麻。
Trends Pharmacol Sci. 2017 Mar;38(3):257-276. doi: 10.1016/j.tips.2016.12.003. Epub 2017 Feb 2.
4
Protein-bound uremic toxins: new insight from clinical studies.蛋白结合型尿毒症毒素:来自临床研究的新见解。
Toxins (Basel). 2011 Jul;3(7):911-9. doi: 10.3390/toxins3070911. Epub 2011 Jul 20.
5
Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets.代谢组学揭示了 HIV 感染患者口腔代谢物的差异水平:寻求新的诊断靶点。
OMICS. 2013 Jan;17(1):5-15. doi: 10.1089/omi.2011.0035. Epub 2011 Jul 13.
6
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.影响人体药物代谢的重要宿主-微生物群代谢相互作用的药物代谢组学鉴定。
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14728-33. doi: 10.1073/pnas.0904489106. Epub 2009 Aug 10.
7
Styrene trimer may increase thyroid hormone levels via down-regulation of the aryl hydrocarbon receptor (AhR) target gene UDP-glucuronosyltransferase.苯乙烯三聚体可能通过下调芳烃受体(AhR)靶基因尿苷二磷酸葡萄糖醛酸基转移酶来提高甲状腺激素水平。
Environ Health Perspect. 2008 Jun;116(6):740-5. doi: 10.1289/ehp.10724.
8
Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression.人类孕烷X受体(PXR)变体及其对人类尿苷二磷酸葡萄糖醛酸基转移酶基因表达调控的差异影响。
Drug Metab Dispos. 2004 Mar;32(3):340-7. doi: 10.1124/dmd.32.3.340.
9
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.婴儿肝脏和肾脏全身清除途径的个体发生:第一部分。
Clin Pharmacokinet. 2002;41(12):959-98. doi: 10.2165/00003088-200241120-00003.
10
Glucuronidation in humans. Pharmacogenetic and developmental aspects.人类的葡萄糖醛酸化作用。药物遗传学及发育方面。
Clin Pharmacokinet. 1999 Jun;36(6):439-52. doi: 10.2165/00003088-199936060-00005.

本文引用的文献

1
STUDIES ON THE INHERITANCE OF CRIGLER--NAJJAR'S SYNDROME BY THE MENTHOL TEST.通过薄荷醇试验对克里格勒 - 纳贾尔综合征遗传的研究。
Acta Paediatr Acad Sci Hung. 1963;4:153-8.
2
Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults.青少年及成人中无明显溶血迹象的慢性非结合胆红素血症。
J Clin Invest. 1962 Dec;41(12):2233-45. doi: 10.1172/JCI104682.
3
Sulphation catalysed by the human cytosolic sulphotransferases--chemical defence or molecular terrorism?人胞质磺基转移酶催化的硫酸化作用——化学防御还是分子恐怖主义?
Hum Exp Toxicol. 1996 Jul;15(7):547-55. doi: 10.1177/096032719601500701.
4
Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine.偏头痛患者血小板对多巴胺和5-羟色胺的酚磺基转移酶活性降低。
Eur J Clin Pharmacol. 1995;49(1-2):109-14. doi: 10.1007/BF00192368.
5
Effect of structurally diverse peroxisome proliferators on rat hepatic sulfotransferase.结构多样的过氧化物酶体增殖剂对大鼠肝脏磺基转移酶的影响。
Chem Biol Interact. 1996 Jan 5;99(1-3):73-84. doi: 10.1016/0009-2797(95)03661-x.
6
Proposed active site domain in estrogen sulfotransferase as determined by mutational analysis.通过突变分析确定的雌激素磺基转移酶中拟议的活性位点结构域。
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12328-32. doi: 10.1073/pnas.92.26.12328.
7
Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome.胆红素UDP-葡萄糖醛酸基转移酶基因启动子的遗传变异与吉尔伯特综合征
Lancet. 1996 Mar 2;347(9001):578-81. doi: 10.1016/s0140-6736(96)91273-8.
8
Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam.(S)-奥沙西泮葡萄糖醛酸化的个体间变异性与(R)-奥沙西泮的形成对比。
Pharmacogenetics. 1995 Oct;5(5):287-97. doi: 10.1097/00008571-199510000-00004.
9
Preparation and characterization of anti-peptide antibodies directed against human phenol and hydroxysteroid sulphotransferases.针对人酚和羟基类固醇磺基转移酶的抗肽抗体的制备与表征
J Pharmacol Toxicol Methods. 1995 Oct;34(2):89-95. doi: 10.1016/1056-8719(95)00041-f.
10
Human estrogen sulfotransferase gene (STE): cloning, structure, and chromosomal localization.人类雌激素磺基转移酶基因(STE):克隆、结构及染色体定位
Genomics. 1995 Sep 1;29(1):16-23. doi: 10.1006/geno.1995.1210.